Japan· JP-3999028F1025
エルトロンボパグ オラミン
A medicinal product containing エルトロンボパグ オラミン, registered in Japan by ノバルティス ファーマ, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- エルトロンボパグ オラミン
- Manufacturer
- ノバルティス ファーマ
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
エルトロンボパグ オラミン in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsEltrombopag Abdi 25 mg filmomhulde tablettenAbdi Farma GmbH
- SwedenEltrombopag Accord 12,5 mg Filmdragerad tablettAccord Healthcare S.L.U.
- SwitzerlandEltrombopag Accord
- SpainELTROMBOPAG ACCORD 12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAccord Healthcare S.L.U.
- PolandEltrombopag AccordAccord Healthcare S.L.U.
- United KingdomEltrombopag 25mg tabletsViatris UK Healthcare Ltd
- GermanyEltrombopag 1 A Pharma1 A Pharma Gmbh
- NorwayEltrombopag AccordAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Elrevolan, Eltrombopag +pharma
- Belgium · Eltrombopag Krka
- Bulgaria · Eltrombopag Pharmascience, Eltrombopag Pharmdedict
- Cyprus · Eltrombopag Msn, Eltrombopag Sandoz
- Czechia · Eltrombopag Abdi, Eltrombopag Krka
- Germany · Eltrombopag 1 A Pharma, Eltrombopag Abdi
- Denmark · Eltrombopag Glenmark, Eltrombopag Krka
- Estonia · Eltrombopag Krka, Eltrombopag Msn
- Spain · Eltrombgopa Glenmark, Eltrombopag Aurovitas Spain
- Finland · Eltrombopag Avansor, Eltrombopag Krka
- France · Eltrombopag Biogaran, Eltrombopag Eg
- United Kingdom (Northern Ireland) · Eltrombopag Abdi, Eltrombopag Accord
- Greece · Eltrombopag Anabiosis, Eltrombopag Faran
- Croatia · Eltrombopag Alpha-Medical, Eltrombopag Msn
- Hungary · Elrevolan, Eltrombopag Elpen
- Ireland · Eltrombopag Clonmel, Eltrombopag Krka
- Iceland · Eltrombopag Accord, Eltrombopag Coripharma
- Italy · Elrevolan, Eltrombopag Abdi
- Liechtenstein · Eltrombopag Accord, Eltrombopag Viatris
- Lithuania · Eltrombopag Krka, Eltrombopag Msn
- Latvia · Eltrombopag Krka, Eltrombopag Olpha
- Malta · Eltrombopag Aspen, Eltrombopag Clonmel
- Netherlands · Eltrombopag Abdi, Eltrombopag Amarox
- Norway · Eltrombopag Accord, Eltrombopag Glenmark
- Poland · Eltrombopag Glenmark, Eltrombopag Krka
- Portugal · Eltrombopag Bluepharma, Eltrombopag Cipla
- Romania · Eltrombopag Dr. Reddy’s, Eltrombopag Msn
- Sweden · Eltrombopag Anabiosis, Eltrombopag Avansor
- Slovenia · Eltrombopag Krka, Eltrombopag Msn
- Slovakia · Eltrombopag Glenmark, Eltrombopag Krka
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/417f85d8-5f9f-4c9f-a8f7-57d739f144bb GET /v1/drugs/417f85d8-5f9f-4c9f-a8f7-57d739f144bb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１２．５ｍｇ１錠",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "3999028F1025",
"category": "内用薬",
"price_yen": 1848.1,
"generic_name": "エルトロンボパグ オラミン",
"product_name_jp": null,
"therapeutic_class": "3999",
"transitional_expiry": null
}See everything about エルトロンボパグ オラミン.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.